Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038187 (
starvation
)
24,951
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The stringent response, an adaptive response to nutrient limitation and exposure to xenobiotics in bacteria, is mediated by two intracellular signaling molecules, pppGpp and ppGpp, together called (p)ppGpp. The cellular level of (p)ppGpp in bacterial cells is controlled by the Rel/Spo family of proteins. In the
cholera
pathogen,
Vibrio cholerae
, (p)ppGpp metabolism is regulated by the products of at least three genes
relA
,
spoT
, and
relV
. In this study, we identify and characterize the function of the guanosine-5'-triphosphate 3'-diphosphate pyrophosphatase A (GppA) encoding gene
gppA
of
V. cholerae
. Genomic analysis indicates that the
gppA
locus is conserved in vibrios and organized as a bicistronic operon along with the
rhlB
gene. We engineered the genome of
V. cholerae
to develop different mutants devoid of GppA and/or other phosphate metabolic enzymes. Our findings indicate that in
V. cholerae
, GppA plays an important role in the conversion of pppGpp to ppGpp during amino acid deprivation but not during glucose
starvation
. Quantitative analyses of the
gppA
transcript level reveal its differential expression pattern at different growth phases and
starvation
conditions. It has been observed that the GppA deficiency during amino acid
starvation
condition could be complemented by overexpressing the exopolyphosphatase coding gene
ppx
of
V. cholerae
. By deletion analysis, we further demonstrate that the amino and carboxy terminal sequences flanking the Ppx-GppA motif of the GppA protein of
V. cholerae
are also important for its enzymatic function.
...
PMID:Functional Insights Into the Role of
gppA
in (p)ppGpp Metabolism of
Vibrio cholerae
. 3311 11
Single cell microorganisms including pathogens relentlessly face myriads of physicochemical stresses in their living environment. In order to survive and multiply under such unfavorable conditions, microbes have evolved with complex genetic networks, which allow them to sense and respond against these stresses. Stringent response is one such adaptive mechanism where bacteria can survive under nutrient
starvation
and other related stresses. The effector molecules for the stringent response are guanosine-5'-triphosphate 3'-diphosphate (pppGpp) and guanosine-3', 5'-bis(diphosphate) (ppGpp), together called (p)ppGpp. These effector molecules are now emerging as master regulators for several physiological processes of bacteria including virulence, persistence, and antimicrobial resistance. (p)ppGpp may work independently or along with its cofactor DksA to modulate the activities of its prime target RNA polymerase and other metabolic enzymes, which are involved in different biosynthetic pathways. Enzymes involved in (p)ppGpp metabolisms are ubiquitously present in bacteria and categorized them into three classes, i.e., canonical (p)ppGpp synthetase (RelA), (p)ppGpp hydrolase/synthetase (SpoT/Rel/RSH), and small alarmone synthetases (SAS). While RelA gets activated in response to amino acid
starvation
, enzymes belonging to SpoT/Rel/RSH and SAS family can synthesize (p)ppGpp in response to glucose
starvation
and several other stress conditions. In this review, we will discuss about the current status of the following aspects: (i) diversity of (p)ppGpp biosynthetic enzymes among different bacterial species including enteropathogens, (ii) signals that modulate the activity of (p)ppGpp synthetase and hydrolase, (iii) effect of (p)ppGpp in the production of antibiotics, and (iv) role of (p)ppGpp in the emergence of antibiotic resistant pathogens. Emphasis has been given to the
cholera
pathogen
Vibrio cholerae
due to its sophisticated and complex (p)ppGpp metabolic pathways, rapid mutational rate, and acquisition of antimicrobial resistance determinants through horizontal gene transfer. Finally, we discuss the prospect of (p)ppGpp metabolic enzymes as potential targets for developing antibiotic adjuvants and tackling persistence of infections.
...
PMID:(p)ppGpp Metabolism and Antimicrobial Resistance in Bacterial Pathogens. 3316 48
<< Previous
1
2
3
4
5
6
7
8